S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.42 (+2.08%)
MSFT   247.99 (+3.01%)
META   139.90 (+0.93%)
GOOGL   101.23 (+2.63%)
AMZN   120.70 (+4.16%)
TSLA   248.08 (+2.34%)
NVDA   130.91 (+4.63%)
NIO   16.63 (+7.36%)
BABA   84.19 (+4.65%)
AMD   67.71 (+2.42%)
T   16.02 (+0.75%)
MU   53.91 (+4.23%)
CGC   3.11 (+6.87%)
F   12.29 (+7.15%)
GE   67.22 (+5.69%)
DIS   100.87 (+3.85%)
AMC   7.83 (+13.81%)
PYPL   92.48 (+6.08%)
PFE   44.32 (+0.41%)
NFLX   238.20 (-0.35%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.42 (+2.08%)
MSFT   247.99 (+3.01%)
META   139.90 (+0.93%)
GOOGL   101.23 (+2.63%)
AMZN   120.70 (+4.16%)
TSLA   248.08 (+2.34%)
NVDA   130.91 (+4.63%)
NIO   16.63 (+7.36%)
BABA   84.19 (+4.65%)
AMD   67.71 (+2.42%)
T   16.02 (+0.75%)
MU   53.91 (+4.23%)
CGC   3.11 (+6.87%)
F   12.29 (+7.15%)
GE   67.22 (+5.69%)
DIS   100.87 (+3.85%)
AMC   7.83 (+13.81%)
PYPL   92.48 (+6.08%)
PFE   44.32 (+0.41%)
NFLX   238.20 (-0.35%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.42 (+2.08%)
MSFT   247.99 (+3.01%)
META   139.90 (+0.93%)
GOOGL   101.23 (+2.63%)
AMZN   120.70 (+4.16%)
TSLA   248.08 (+2.34%)
NVDA   130.91 (+4.63%)
NIO   16.63 (+7.36%)
BABA   84.19 (+4.65%)
AMD   67.71 (+2.42%)
T   16.02 (+0.75%)
MU   53.91 (+4.23%)
CGC   3.11 (+6.87%)
F   12.29 (+7.15%)
GE   67.22 (+5.69%)
DIS   100.87 (+3.85%)
AMC   7.83 (+13.81%)
PYPL   92.48 (+6.08%)
PFE   44.32 (+0.41%)
NFLX   238.20 (-0.35%)
S&P 500   3,778.51 (+2.72%)
DOW   30,209.96 (+2.44%)
QQQ   281.10 (+2.77%)
AAPL   145.42 (+2.08%)
MSFT   247.99 (+3.01%)
META   139.90 (+0.93%)
GOOGL   101.23 (+2.63%)
AMZN   120.70 (+4.16%)
TSLA   248.08 (+2.34%)
NVDA   130.91 (+4.63%)
NIO   16.63 (+7.36%)
BABA   84.19 (+4.65%)
AMD   67.71 (+2.42%)
T   16.02 (+0.75%)
MU   53.91 (+4.23%)
CGC   3.11 (+6.87%)
F   12.29 (+7.15%)
GE   67.22 (+5.69%)
DIS   100.87 (+3.85%)
AMC   7.83 (+13.81%)
PYPL   92.48 (+6.08%)
PFE   44.32 (+0.41%)
NFLX   238.20 (-0.35%)
OTCMKTS:GBLX

GB Sciences - GBLX Stock Forecast, Price & News

$0.03
0.00 (0.00%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.03
52-Week Range
$0.02
$0.04
Volume
97,702 shs
Average Volume
185,826 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBLX stock logo

About GB Sciences (OTCMKTS:GBLX) Stock

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

GBLX Stock News Headlines

GB Sciences, Inc. (GBLX)
UPDATE: Gb Sciences Issues Shareholder Letter
Gb Sciences Issues Summary Shareholder Letter
See More Headlines
Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

GBLX Company Calendar

Last Earnings
11/14/2016
Today
10/04/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
Cannabis
Sector
Medical
Current Symbol
OTCMKTS:GBLX
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. John Claybron Poss (Age 74)
    Chairman & CEO
    Comp: $102.82k
  • Dr. Andrea Small-Howard M.B.A. (Age 53)
    MBA, Ph.D., Chairman of Scientific Advisory Board, Chief Science Officer, Pres & Director
    Comp: $177.85k
  • Mr. Zach Swarts (Age 34)
    CFO, Chief Accounting Officer & Treasurer
    Comp: $128.25k
  • Mr. Krin Ellery Kuethe (Age 38)
    Sr. VP of Cultivation
  • Mr. Gary R. Henrie Esq.
    Securities Counsel & Company Sec.













GBLX Stock - Frequently Asked Questions

How have GBLX shares performed in 2022?

GB Sciences' stock was trading at $0.0205 at the start of the year. Since then, GBLX stock has increased by 31.2% and is now trading at $0.0269.
View the best growth stocks for 2022 here
.

Are investors shorting GB Sciences?

GB Sciences saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 34,200 shares, an increase of 100.0% from the August 31st total of 17,100 shares. Based on an average daily trading volume, of 155,300 shares, the days-to-cover ratio is currently 0.2 days.
View GB Sciences' Short Interest
.

How were GB Sciences' earnings last quarter?

GB Sciences, Inc. (OTCMKTS:GBLX) released its quarterly earnings data on Monday, November, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.

What other stocks do shareholders of GB Sciences own?
What is GB Sciences' stock symbol?

GB Sciences trades on the OTCMKTS under the ticker symbol "GBLX."

How do I buy shares of GB Sciences?

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GB Sciences' stock price today?

One share of GBLX stock can currently be purchased for approximately $0.03.

How can I contact GB Sciences?

GB Sciences' mailing address is 6450 Cameron St Ste 110A, LAS VEGAS, NV 89118-4337, United States. The official website for the company is gbsciences.com. The company can be reached via phone at (866) 721-0297.

This page (OTCMKTS:GBLX) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.